- Report
- February 2023
- 123 Pages
Global
From €5232EUR$5,500USD£4,454GBP
- Report
- June 2021
- 177 Pages
Global
From €4709EUR$4,950USD£4,008GBP
- Report
- April 2022
- 193 Pages
Global
From €5660EUR$5,950USD£4,818GBP
- Report
- September 2018
- 93 Pages
Global
From €4709EUR$4,950USD£4,008GBP
- Report
- April 2018
Global
From €2854EUR$3,000USD£2,429GBP
- Report
- May 2023
- 156 Pages
Global
From €3030EUR$3,185USD£2,579GBP
€4329EUR$4,550USD£3,685GBP
- Report
- April 2023
- 114 Pages
Global
From €4519EUR$4,750USD£3,846GBP
- Report
- December 2023
- 108 Pages
Global
From €4043EUR$4,250USD£3,442GBP
- Book
- January 2016
- 472 Pages
- Book
- August 2013
- 386 Pages
- Book
- November 2013
- 744 Pages
Biologics Development is a field of drug discovery that focuses on the development of biopharmaceuticals, which are drugs derived from living organisms. This includes proteins, peptides, nucleic acids, and other molecules. The process of biologics development involves the identification of a target molecule, the design of a drug to interact with the target, and the production of the drug. The development of biologics requires a deep understanding of the biology of the target molecule, as well as the ability to produce the drug in a cost-effective manner.
Biologics Development is a rapidly growing field, with many companies investing in the development of new biopharmaceuticals. Companies such as Amgen, Biogen, Genentech, and Novartis are leading the way in the development of biologics. Other companies such as AbbVie, AstraZeneca, and Merck are also investing in the development of biologics. These companies are working to develop new treatments for a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. Show Less Read more